Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes of the Japan Diabetes Society (English version).
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. Shimada A, et al. Among authors: abiru n. J Diabetes Investig. 2024 Feb;15(2):254-257. doi: 10.1111/jdi.14121. Epub 2024 Jan 7. J Diabetes Investig. 2024. PMID: 38184802 Free PMC article.
New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version).
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. Shimada A, et al. Among authors: abiru n. Diabetol Int. 2024 Jan 8;15(1):1-4. doi: 10.1007/s13340-023-00679-1. eCollection 2024 Jan. Diabetol Int. 2024. PMID: 38264233
Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes.
Kawasaki E, Shimada A, Imagawa A, Abiru N, Awata T, Oikawa Y, Osawa H, Kawabata Y, Kozawa J, Kobayashi T, Takahashi K, Chujo D, Fukui T, Miura J, Yasuda K, Yasuda H, Kajio H, Hanafusa T, Ikegami H; Committee of type 1 diabetes, Japan Diabetes Society. Kawasaki E, et al. Among authors: abiru n. J Diabetes Investig. 2023 Apr;14(4):570-581. doi: 10.1111/jdi.13980. Epub 2023 Jan 23. J Diabetes Investig. 2023. PMID: 36691729 Free PMC article.
Correction: New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from Committee on Type 1 Diabetes in Japan Diabetes Society (English version).
Shimada A, Kawasaki E, Abiru N, Awata T, Oikawa Y, Osawa H, Kajio H, Kozawa J, Takahashi K, Chujo D, Noso S, Fukui T, Miura J, Yasuda K, Yasuda H, Imagawa A, Ikegami H. Shimada A, et al. Among authors: abiru n. Diabetol Int. 2024 Mar 7;15(3):638-639. doi: 10.1007/s13340-024-00702-z. eCollection 2024 Jul. Diabetol Int. 2024. PMID: 39101174 Free article.
Glucagon secretion and its association with glycaemic control and ketogenesis during sodium-glucose cotransporter 2 inhibition by ipragliflozin in people with type 1 diabetes: Results from the multicentre, open-label, prospective study.
Nakamura Y, Horie I, Kitamura T, Kusunoki Y, Nishida K, Yamamoto A, Hirota Y, Fukui T, Maeda Y, Minami M, Matsui T, Kawakami A, Abiru N. Nakamura Y, et al. Among authors: abiru n. Diabetes Obes Metab. 2024 May;26(5):1605-1614. doi: 10.1111/dom.15458. Epub 2024 Jan 22. Diabetes Obes Metab. 2024. PMID: 38253809
Insulin response after treatment depends on fasting plasma glucose level in NIDDM.
Matsumoto K, Akazawa S, Abiru N, Yano M, Ishibasi M, Uotani S, Matsuo H, Kawasaki E, Yamasaki H, Yamamoto H, et al. Matsumoto K, et al. Among authors: abiru n. Diabetes Res Clin Pract. 1994 Dec 16;26(2):129-35. doi: 10.1016/0168-8227(94)90150-3. Diabetes Res Clin Pract. 1994. PMID: 7705194 Clinical Trial.
133 results